AAD: Long-Term Improvement Seen With Ruxolitinib in Vitiligo
Improvement in facial/total Vitiligo Area Scoring Index seen with continued treatment from weeks 52 to 104
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.